Logo image
CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa: A Brief Methodology
Journal article

CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa: A Brief Methodology

Wen-Hsuan Wu, Yi-Ting Tsai, Sally Justus, Galaxy Y Cho, Jesse D Sengillo, Yu Xu, Thiago Cabral, Chyuan-Sheng Lin, Alexander G Bassuk, Vinit B Mahajan, …
Methods in molecular biology (Clifton, N.J.), Vol.1715, pp.191-205
2018
DOI: 10.1007/978-1-4939-7522-8_13
PMCID: PMC9119419
PMID: 29188514
url
https://www.ncbi.nlm.nih.gov/pmc/articles/9119419View
Open Access

Abstract

CRISPR/Cas9 genome engineering is currently the leading genome surgery technology in most genetics laboratories. Combined with other complementary techniques, it serves as a powerful tool for uncovering genotype-phenotype correlations. Here, we describe a simplified protocol that was used in our publication, CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa, providing an overview of each section of the experimental process.
Genetic Engineering - methods Retinitis Pigmentosa - genetics Male Cyclic Nucleotide Phosphodiesterases, Type 6 - genetics Animals DNA Repair CRISPR-Cas Systems Female Mice RNA, Guide Mutation Genetic Vectors Disease Models, Animal

Details

Metrics

Logo image